Ledger.Open graph →
SEC Form D · filed October 27, 2022

CTRL Therapeutics USA, Inc

Offering
$10.6M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLENCOE, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Elena Viboch · Glencoe, ILDirectorMichael Kalos · Dartmouth, Nova Scotia, CanadaDirectorShana Kelley · Glencoe, ILExec · DirectorDavid O'Neill · New York, NYDirectorMichael Kalos · Dartmouth, Nova Scotia, CanadaDirectorShana Kelley · Glencoe, ILExec · DirectorElena Viboch · Glencoe, ILDirectorDavid O'Neill · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗